Universe · entity
GREAT POINT PARTNERS LLC
Institutional manager (13F) · CIK 1281446
13F holdings · as of 2026-03-31 · top 39 · reported portfolio $408M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | $31M | 374,000 |
| 2 | VOR BIOPHARMA INC | $31M | 1,750,000 |
| 3 | ZURA BIO LTD | $25M | 4,215,930 |
| 4 | AMYLYX PHARMACEUTICALS INC | $24M | 1,750,000 |
| 5 | NEKTAR THERAPEUTICS | $23M | 316,453 |
| 6 | SOL-GEL TECHNOLOGIES LTD | $22M | 274,363 |
| 7 | ALUMIS INC | $19M | 856,061 |
| 8 | BRIGHT MINDS BIOSCIENCES INC | $16M | 220,000 |
| 9 | ANNEXON INC | $14M | 2,500,000 |
| 10 | KALVISTA PHARMACEUTICALS INC | $14M | 675,000 |
| 11 | IMMUNOVANT INC | $14M | 545,625 |
| 12 | JADE BIOSCIENCES INC | $14M | 964,462 |
| 13 | CONTINEUM THERAPEUTICS INC | $10M | 800,198 |
| 14 | ZENAS BIOPHARMA INC | $10M | 524,066 |
| 15 | NEUROGENE INC | $10M | 500,000 |
| 16 | MOONLAKE IMMUNOTHERAPEUTICS | $9M | 500,000 |
| 17 | CLIMB BIO INC | $9M | 1,334,130 |
| 18 | ORUKA THERAPEUTICS INC | $9M | 183,330 |
| 19 | EUPRAXIA PHARMACEUTICALS INC | $9M | 1,200,000 |
| 20 | VERA THERAPEUTICS INC | $8M | 199,348 |
| 21 | EVOMMUNE INC | $7M | 325,000 |
| 22 | LB PHARMACEUTICALS INC | $7M | 300,000 |
| 23 | COMPASS THERAPEUTICS INC | $7M | 1,350,000 |
| 24 | SCYNEXIS INC | $7M | 7,554,347 |
| 25 | PALISADE BIO INC | $6M | 3,405,757 |
| 26 | CONTEXT THERAPEUTICS INC | $6M | 2,238,496 |
| 27 | RELMADA THERAPEUTICS INC | $6M | 842,106 |
| 28 | SILENCE THERAPEUTICS PLC | $5M | 1,020,489 |
| 29 | UNICYCIVE THERAPEUTICS INC | $5M | 796,558 |
| 30 | TENAX THERAPEUTICS INC | $5M | 327,307 |
| 31 | PROMIS NEUROSCIENCES INC | $5M | 371,402 |
| 32 | CULLINAN THERAPEUTICS INC | $4M | 300,000 |
| 33 | IMMIX BIOPHARMA INC | $3M | 350,000 |
| 34 | REZOLUTE INC | $3M | 951,809 |
| 35 | PHARVARIS N V | $2M | 82,800 |
| 36 | HUMACYTE INC | $2M | 3,750,000 |
| 37 | AVALO THERAPEUTICS INC | $2M | 124,666 |
| 38 | ALKERMES PLC | $2M | 50,000 |
| 39 | OPUS GENETICS INC | $1M | 324,340 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.